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Catherine E Creeley1*, Krikor T Dikranian3, Stephen A Johnson1, Nuri B Farber1 and John W Olney1,2
Abstract
Background: In utero exposure of the fetal non-human primate (NHP) brain to alcohol on a single occasion during
early or late third-trimester gestation triggers widespread acute apoptotic death of cells in both gray and white
matter (WM) regions of the fetal brain. In a prior publication, we documented that the dying gray matter cells are
neurons, and described the regional distribution and magnitude of this cell death response. Here, we present new
findings regarding the magnitude, identity and maturational status of the dying WM cells in these alcohol-exposed
fetal NHP brains.
Results: Our findings document that the dying WM cells belong to the oligodendrocyte (OL) lineage. OLs become
vulnerable when they are just beginning to generate myelin basic protein in preparation for myelinating axons, and
they remain vulnerable throughout later stages of myelination. We found no evidence linking astrocytes, microglia
or OL progenitors to this WM cell death response. The mean density (profiles per mm3) of dying WM cells in
alcohol-exposed brains was 12.7 times higher than the mean density of WM cells dying by natural apoptosis in
drug-naive control brains.
Conclusions: In utero exposure of the fetal NHP brain to alcohol on a single occasion triggers widespread acute
apoptotic death of neurons (previous study) and of OLs (present study) throughout WM regions of the developing
brain. The rate of OL apoptosis in alcohol-exposed brains was 12.7 times higher than the natural OL apoptosis rate.
OLs become sensitive to the apoptogenic action of alcohol when they are just beginning to generate constituents
of myelin in their cytoplasm, and they remain vulnerable throughout later stages of myelination. There is growing
evidence for a similar apoptotic response of both neurons and OLs following exposure of the developing brain to
anesthetic and anticonvulsant drugs. Collectively, this body of evidence raises important questions regarding the
role that neuro and oligo apoptosis may play in the human condition known as fetal alcohol spectrum disorder
(FASD), and also poses a question whether other apoptogenic drugs, although long considered safe for pediatric/
obstetric use, may have the potential to cause iatrogenic FASD-like developmental disability syndromes.
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Background
Several classes of drugs, including NMDA antagonists
[1], GABAA agonists and alcohol [2,3], which has both
NMDA antagonist and GABA agonist properties, trigger
widespread neuroapoptosis throughout the developing
brain of several animal species [3-11], including non-
human primates [12-19]. Included among drugs that
have apoptogenic potential are several that are some-
times abused by pregnant women (alcohol, PCP,
ketamine, benzodiazepines, barbiturates) and many that
are used frequently in pediatric and obstetric medi-
cine (sedatives, anesthetics, anticonvulsants)(reviewed
in Creeley and Olney [20]). Evidence documenting
neuroapoptosis induced by alcohol and anesthetic
drugs is particularly concerning in that millions of
human fetuses or infants, every year throughout the
world, are exposed to one or more of these agents.
The period of peak sensitivity to this neurotoxic
mechanism coincides with the brain growth spurt
[1,2], during which neurons throughout the brain are
undergoing rapid synaptogenesis. In rodents, the brain
growth spurt is confined primarily to the first several
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weeks after birth, but in humans it spans from mid gesta-
tion to several years after birth [21]. During this sensitive
period, a single drug exposure, at clinically relevant doses,
is sufficient to trigger apoptosis of neurons through-
out many regions of the brain [3-7,10,11], and cause
long-term neurobehavioral disturbances in both ro-
dents [6,20-22] and NHPs [16].
The human relevance of the above findings remains to
be fully elucidated. It is well recognized that alcohol can
damage the developing human brain and cause a wide
variety of neurodevelopmental disabilities referred to as
Fetal Alcohol Spectrum Disorders (FASD) [23-25]. Ini-
tially, doubts were raised whether anesthetic drugs can
cause similar outcomes [26,27], but recently reported
evidence from several independent research groups sug-
gests that brief exposure of human infants to anesthesia
is associated with increased risk for neurobehavioral dis-
turbances, including learning disabilities and attention
deficit/hyperactivity disorder [28-34]. While the original
findings pertaining to the apoptogenic action of alcohol
and anesthetic drugs on the developing brain were de-
scribed exclusively in terms of an impact on various
neuronal populations, we recently reported that expos-
ure of the neonatal NHP brain to isoflurane [35] or
propofol [14] anesthesia triggers a robust apoptotic cell
death reaction affecting both neurons and oligodendro-
glia [OL]. Guerri et al. [36], based primarily on in vitro
findings, have championed the hypothesis that alcohol
might have a toxic effect on astroglia, but OLs have not
been suspected of being a target of alcohol’s toxic action.
We have reported that exposure of the fetal NHP brain
to alcohol on a single occasion can cause widespread
death of neurons [15]. In the course of that study, we
made the preliminary unreported observation that there
was immunohistochemical evidence of a cell death reac-
tion distributed diffusely throughout white matter (WM)
regions of these brains. The present study was under-
taken to clarify the nature and extent of this toxic reac-
tion to alcohol in WM regions of these alcohol-exposed
NHP fetal brains.
Results
Following up on our preliminary observation that sec-
tions from alcohol-exposed fetal NHP brains have abun-
dant AC3-positive profiles distributed widely throughout
WM regions [Figure 1a], we stained sections adjacent to
the AC3-stained sections with the DeOlmos cupric silver
method (marker for dying cells), and observed that
approximately the same number of cells in the same
WM locations were silver positive [Figure 1b], which
provides confirmatory evidence that these WM cells
are undergoing cell death. There is evidence that cells
in the OL lineage can be stained with antibodies to
fractin when they are undergoing apoptotic degeneration
[37,38]. Therefore, we stained sections adjacent to those
we had stained for AC3 or silver, with antibodies to
fractin, and found that fractin staining readily detected a
similar number of cells in the same WM locations
[Figure 1c], and the appearance of these degenerating
WM cells when stained with fractin was very similar
to their appearance when stained with AC3 or silver
[compare Figure 1a,b,c].
The majority of cells in the WM are either astrocytes
or OLs. Therefore, next we performed an immunofluor-
escent double staining experiment in which AC3-stained
sections were also stained with antibodies against GFAP
(marker for astrocytes), and found that the AC3-positive
profiles did not co-label for GFAP, therefore were not
astrocytes [Figure 1d]. In other double staining experi-
ments, consistent with our previously published evi-
dence [35] pertaining to isoflurane-induced apoptosis of
OLs, we found that AC3-positive profiles in the WM did
not co-label for neuN, PDGFRα, or Iba1, signifying that
the vulnerable WM cell is not a neuron, or OL progeni-
tor or a microglial cell.
Collectively, the above findings support the hypothesis
that the vulnerable WM cells are OLs that are beyond
the progenitor stage of maturation, i.e., OLs that are
engaged, or are preparing to engage in myelination. To
test this hypothesis we used IHC staining with anti-
bodies to myelin basic protein (MBP) as our primary
tool, because MBP IHC provides a means of studying
both the myelination process and the role of OLs in
mediating that process. We performed MBP staining at
several rostrocaudal levels and will present the findings
at a rostral level where little or no myelination was
Figure 1 Histological appearance of apoptotic profiles in
frontal subcortical white matter (WM) of alcohol-exposed G120
fetal NHP brain. Panel (a) depicts the appearance of degenerating
WM cells stained with antibodies to AC3, and panels (b) and (c) are
from adjacent sections stained with silver or antibodies to fractin. All
three of these cell death markers detect a similar number of
degenerating profiles in the same WM location, and the dying cells
have a similar morphological appearance, regardless whether
stained by AC3, silver or fractin. Panel (d) displays a WM scene from
the same brain immunofluorescently double stained with antibodies
to AC3 and GFAP, showing three astrocytes stained with GFAP
(green) beside a dying cell stained by AC3 (red). The dying cell is
marked by AC3 but not GFAP, signifying that it is not an astrocyte.
Scale bar in d = 15 μM for all four panels.
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occurring, a mid-rostrocaudal level where there was
abundant evidence for early myelination, and a caudal
level where WM pathways were densely myelinated.
Findings at a rostral level
In sections from the G120 brain cut through the frontal
cortex at or rostral to the level of the septum, MBP
staining revealed no evidence for myelination [Figure 2a],
but at this level there were numerous MBP-positive
immature OLs which, judged by their MBP content,
were in a state of readiness to begin the myelination
process. All of the MBP-positive WM cells at this rostral
level had a similar morphology characterized by a dense
arbor of radially oriented processes, each of which
displayed web-like protoplasmic extensions [Figure 2b].
In alcohol-exposed brains, some of these MBP-positive
OLs appeared to be undergoing degeneration, as was
evidenced by a halo of particulate debris surrounding
the cell body in starburst configuration [Figure 2c],
resembling the appearance of degenerating WM profiles
stained with silver or fractin [compare Figures 1b and c
with 2c]. In double staining experiments it was readily
determined that AC3-positive profiles were typically also
MBP-positive (Figures 2d,e,f ), and DAPI counterstaining
revealed an abnormal nuclear chromatin pattern indicative
of apoptotic cell death [Figure 2f inset). These findings
document that OLs are vulnerable, and onset of vulner-
ability coincides with the stage when OLs are beginning to
synthesize MBP in preparation for myelinating axons. In
the literature, OLs at this stage of maturation have been
given various designations [37,39,40], depending on the
model studied and immunological reagents used. In this
writing we will use the nomenclature recommended by
Butt and Berry [40] which recognizes a progenitor stage in
which the OL cell body stains positive for PDGFRα and
negative for MBP. The next stage is the promyelination
stage in which the OL cell body becomes positive for MBP
and negative for PDGFRα. In this stage the OL is accumu-
lating MBP and other constituents of myelin in its cyto-
plasm in preparation to begin myelinating axons. When
the promyelinating OL begins ensheathing axons and
transferring MBP to the sheaths, it is referred to as a
myelinating OL, which stains positive for MBP, as do the
newly formed myelin sheaths.
Findings at a mid-rostrocaudal level
In sections from G120 brains at a mid-rostrocaudal
level, MBP staining provided evidence for active myelin-
ation in several brain regions, including the centrum
semi-ovale, corona radiata, internal capsule and globus
Figure 2 Section from the rostral forebrain of an alcohol-exposed G120 fetal NHP brain stained with antibodies to MBP, which detects
myelinated axons and OLs that contain MBP in their cytoplasm. Panel (a) is a low magnification overview showing that at this rostral level,
there is no evidence for myelination of developing axonal tracts coursing through WM regions underlying the frontal cortex (FC), such as the
centrum semi-ovale (CSO), corpus callosum (CC), and internal capsule (IC). However, there are many MBP-positive promyelinating OLs visible at
higher magnification. Panel (b) shows the typical appearance of a normal promyelinating OL that contains enough MBP in its cytoplasm to allow
the entire cell to be visualized by MBP staining. At this stage, the OL displays numerous radially oriented processes that have fluffy membranous
extensions. Panel (c) presents the appearance of an MBP-stained promyelinating OL that is undergoing apoptotic cell death following alcohol
exposure. The processes have disintegrated and present as a halo of MBP-positive debris surrounding a condensed cell body. Panels (d), (e), (f)
illustrate an MBP-positive promyelinating OL that co-labels with AC3, signifying that it is dying by apoptosis. An abnormal nuclear chromatin
pattern revealed by DAPI counterstaining (blue, Fig f inset) confirms the apoptosis diagnosis. Scale bar in (c) represents 750 μM in (a), 20 μM in
(b) and (c), and 12 μM in (d-f).
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pallidus [Figure 3a]. At this level, MBP-positive OLs
were plentiful, and many were engaged in myelinating
axons [Figure 3b & c]. Typically, the early myelination
scene featured many small patches of axons undergoing
myelination, each patch being attended by a single OL
that extended its processes to multiple axonal segments
that became visible by virtue of the MBP that the OL
was incorporating into their newly formed sheaths
[Figure 3b,c]. OLs that were actively myelinating axons,
displayed an arbor of multiple slender processes, each of
which contacted and appeared to be myelinating several
axons. Some of these profiles that were engaged in mye-
lination appeared to be degenerating [Figure 3c]. Inter-
estingly, degenerating OLs in MBP-stained sections
presented in two different patterns, depending on the
stage of myelination the OL was in when it committed
to cell death. If commitment occurred before the OL
had effectively transferred its MBP content to axonal
processes, the pattern consisted of MBP-positive debris
in starburst configuration surrounding a condensed cell
body [Figure 2c]. The second pattern consisted of MBP-
positive debris distributed in a linear pattern conforming
to the layout of an axonal patch [Figure 3c], signifying
that the dying OL had committed to cell death after
having already myelinated a group of axons. Double
staining experiments documented that MBP-positive
profiles that were actively engaged in myelination fre-
quently colabeled for AC3 [Figure 3d,e,f], signifying that
they were dying by apoptosis, and DAPI counterstaining
of these profiles revealed an abnormal nuclear chromatin
pattern confirming the apoptosis diagnosis [Figure 3f
inset].
Findings at a caudal level
At a caudal cerebellar/brain stem level, ascending WM
tracts were heavily myelinated and MBP staining pro-
vided an excellent means of visualizing these myelinated
pathways, but MBP did not stain OL cell bodies in these
densely myelinated pathways. However, in alcohol-
exposed brains, if these densely myelinated pathways
were double stained with MBP and AC3, it was possible
to detect many cell bodies that were negative for MBP
and positive for AC3 amid a dense bed of MBP-positive
myelinated axons. In Figure 4a this phenomenon is illus-
trated in the cerebellar peduncle, a very densely myelin-
ated pathway. Staining of adjacent sections with the
silver method (Figure 4b) confirmed that large numbers
of cells with OL morphology were undergoing apoptotic
cell death in the cerebellar peduncle following alcohol
exposure. The observation that two cell death markers
identify many dying cells with typical OL morphology in
a densely myelinated pathway that has no MBP-positive
OL cell bodies, suggests that at this late stage of myelin-
ation, the OL cell bodies have ceased generating new
Figure 3 Section at a mid-rostrocaudal level of an alcohol-
exposd G120 fetal NHP brain stained with antibodies to MBP.
Panel (a) is an overview showing that several regions at this rostrocaudal
level, including centrum semi-ovale (CSO), internal capsule (IC) and
globus pallidus (GP), are undergoing myelination. The boxed region in
(a), shown at higher magnification in (b), depicts the typical appearance
of early myelination, which is characterized by numerous small patches
of axons, each of which is attended by an MBP-positive OL that is
actively myelinating that patch. The box in (b), magnified in (c), shows
one such patch consisting of segments of about 10 axons being
contacted by the processes of a single OL that is wrapping sheets of
MBP-positive membranes around them. Note the intense MBP staining
at the points of contact between OL processes and axonal segments
(arrows). At the middle left and bottom right of panel (c) are MBP-
positive degenerating OLs that committed to cell death after having
transferred MBP to a patch of axonal segments. Note the linear
configuration of the MBP-positive breakdown products that conforms to
the layout of an axonal patch. Panels (d, e, f) are double-stained
immunofluorescent images documenting the typical appearance of an
MBP-positive myelinating OL that co-labels for AC3, signifying that it is
undergoing apoptotic cell death, which is confirmed by DAPI
counterstaining revealing an abnormal nuclear chromatin pattern (blue,
inset panel f). Note that the MBP positive processes of this cell contact
and appear to be confluent with multple axonal segments, and these
same processes are flooded with AC3, even along the surface of the
axonal segments. Scale bar in (c) represents 1000 μM for (a), 100 μM for
(b), 20 μM for (c) and 15 μM for (d,e,f).
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MBP and have transferred all of their MBP content to
myelin sheaths, which do stain positive for MBP.
The illustrations we have chosen to document the ef-
fects of alcohol on the fetal NHP brain are from brain
sections of animals at an age early in the third trimester,
because this documents that the developing primate
brain is vulnerable at the earliest age evaluated in this
study, which is an age when human fetuses are fre-
quently exposed to alcohol. We have previously demon-
strated [35] that isoflurane anesthesia induces a robust
oligoapoptosis response in the primate brain on postna-
tal day 6. In the present study, the response we observed
to alcohol in the G155 fetal brain (1 week before term)
was similarly robust (see quantitative evaluation) and
showed the same specificity for OL lineage cells at or
beyond the maturational stage when they achieve mye-
lination potential. Collectively, our present findings,
together with previous findings [35], document vulner-
ability of the developing primate brain to this toxic
mechanism throughout the third trimester of gestation.
Thus, exposure of the human fetus to alcohol at any
time in the third trimester entails risk of inducing an
oligoapoptosis response in the fetal brain.
Quantitative observations
Quantitative counts performed on WM regions of AC3-
stained brain sections revealed that the mean (± SEM)
density of apoptotic profiles in the 5 ethanol-exposed
brains was 840.3 ± 29.11 profiles/mm3 compared to
66.37 ± 17.97 profiles/mm3 for the 4 control brains
(Figure 5). This amounts to a mean 12.7-fold increase in
glial apoptotic profiles in the alcohol-exposed compared
to the control brains. The difference between the means
was 773.9 (95% confidence interval 678.9 to 868.9, p <
0.0001). While the increase in profile density caused by
ethanol exposure, when averaged across the three ages,
was 12.7 fold, the fold-increase was19.44, 15.27 and 8.45
for the early, mid and late third trimester ages respect-
ively. Thus, the greatest difference between experimental
and control density counts was at the earlier ages. Cell
Figure 4 Scene at a caudal (cerebellar/brainstem) level of an
alcohol-exposed G120 fetal NHP brain. Panels (a) and (b) are
from adjacent sections cut through the cerebellar peduncle. Panel
(a) is stained immunofluorescently with antibodies to MBP (green)
and AC3 (red), and panel (b) is stained with the silver method. In (a),
bundles of heavily myelinated axons are intensely positive for MBP,
and numerous cell bodies are intensely positive for AC3, but there
are no cell bodies that are stained by MBP. The silver stain in (b)
detects numerous dying cells that are present in approximately the
same density as was revealed by AC3 staining (a), which supports
the interpretation that these two cell death markers are detecting
the same population of dying cells, and they have the same
morphological appearance as degenerating OLs in more rostral
brain regions. Scale bar in b = 50 μM for both panels.
Figure 5 Mean (± SEM) density of apoptotic OL profiles per
mm3 of white matter in the brains of alcohol-exposed (n=5)
versus control (n=4) fetal NHPs. To derive these mean density
counts, the following four WM regions were sampled from each
brain: the corona radiata, internal capsule, optic tract and
cerebellar peduncle.
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death counts based on AC3 staining reveals that the
dying OLs in all WM regions at all stages of maturation
have a remarkably similar morphology. While the dens-
ity of degenerating OLs (profiles/mm3) decreased from
the early to late gestation period, the toxic impact
(in terms of total OLs deleted) remained approximately
the same across the different ages because brain mass
increases two-fold between the beginning and end of the
third trimester. Therefore, if the number of deleted OLs
per unit mass of tissue becomes half as many as the tis-
sue mass becomes two times larger, the total number of
deleted OLs remains the same.
Discussion
We have previously reported that a single exposure of
the third trimester fetal cynomolgus macaque to alcohol
causes widespread apoptotic degeneration of neurons
throughout gray matter regions of the developing ma-
caque brain [15]. Here we show in the same group of
NHP subjects that alcohol also causes widespread apop-
totic degeneration of glial cells throughout WM regions,
and the type of glial cell affected is of the oligodendro-
cyte (OL) lineage. During the NHP third trimester, cells
in the OL lineage undergo maturational changes in
which OL progenitors differentiate into promyelinating,
and then myelinating OLs. During the promyelinating
stage they accumulate MBP and other constituents of
myelin in their cytoplasm in preparation for myelinating
axons. Our evidence indicates that it is early in the
promyelination stage that they become vulnerable to
alcohol-induced apoptosis, and they continue to be
vulnerable throughout both early and late stages of
myelination.
An interesting feature of alcohol-induced apoptosis in
both the mouse [7] and monkey brain is that the cell
death reaction affecting both neurons and OLs is bilat-
erally symmetrical. Cell death in any region of gray or
white matter affecting one hemisphere of an alcohol-
exposed brain, is precisely mirrored by the same number
and distribution of dying cells among homologous cell
populations in the contralateral hemisphere. This feature
of alcohol neurotoxicity may significantly limit the cap-
acity for functional recovery, in that the extent of recov-
ery may depend, in part, on the availability of intact
contralateral cell populations with similar functional
properties to fill in for the cell loss.
It is not clear whether alcohol causes oligoapoptosis by
the same mechanism(s) as it causes neuroapoptosis. There
is substantial evidence that the neuroapoptotic action of
alcohol is triggered by a dual mechanism - blockade of
NMDA glutamate receptors and hyperactivation of
GABAA receptors [1-3]. Growing evidence for intimate
glutamatergic and GABAergic signaling between neurons
and OLs via synaptic contacts [41,42] argues in favor of
similar cell surface receptor mechanisms triggering these
two toxic phenomena. It has been demonstrated that
anesthetic drugs with NMDA antagonist or GABAA agon-
ist properties also trigger neuroapoptosis in the developing
rodent [1,5,6,43,44] or NHP [12,14,17-19] brain, and that
anesthetic drugs also trigger oligoapoptosis in the develop-
ing NHP brain [14,35]. Regarding intracellular signaling
pathways that may be involved, it has been shown in the
in vivo mouse brain that this apoptosis process involves
Bax-mediated release of cytochrome c from mitochondria
which results in activation of caspases 9 and 3 [45-47]. An
important upstream event that occurs within minutes
after administration of alcohol or anesthetic drugs (prior
to Bax protein activation), is the suppression of ERK
(extracellular signal-regulated kinase) phosphorylation.
Within minutes after administration, both alcohol and
anesthetic drugs trigger suppression of pERK, and
lithium counteracts this pERK suppressant action, and
prevents alcohol or anesthetic drugs from triggering
neuroapoptosis [48,49]. It remains to be determined
whether these apoptogenic agents suppress ERK phos-
phorylation in oligodendrocytes, and whether lithium
protects against oligoapoptosis induced by these agents.
The neurodevelopmental disabilities associated with
FASD are heterogeneous; in childhood, they vary from
mild attention deficit/hyperactivity disorder (AD/HD)
and related learning disturbances to frank mental retard-
ation [24,25]. Later in life, individuals with a FASD
diagnosis have a high incidence of adult-onset neuro-
psychiatric disturbances, including a 40% incidence of
psychosis and 44% incidence of major depressive dis-
order [23]. The observation that alcohol deletes glia, as
well as neurons, from the developing primate brain, and
that the glial cell type affected is of the OL lineage,
strengthens the proposal that the apoptogenic action of
alcohol can explain a wide range of FASD neuropsychi-
atric disturbances. Deletion of OLs at a stage when
they are just beginning to myelinate axons that intercon-
nect neurons throughout the developing brain, could
add to both the severity and complexity of long term
neurobehavioral consequences of alcohol exposure dur-
ing fetal life.
While the present findings pertain only to alcohol, and
have primary significance in relation to FASD, the po-
tential public health significance is extended by mount-
ing evidence that many drugs (sedatives, anesthetics,
anti-convulsants) used in obstetric and pediatric medi-
cine mimic the apoptogenic action of alcohol in the
developing brains of several animal species, including
NHPs [20]. In addition, a single exposure to these agents
can cause long-term neurobehavioral disturbances in
several animal species [6,16,43,44,50,51] similar to those
caused by alcohol in rodents [22] or in humans [25]. Of
potentially greater import is recent evidence reported
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by several independent research groups [28-34] suggesting
that brief exposure of human infants to anesthesia is asso-
ciated with increased risk for FASD-like neurobehavioral
disturbances, including learning disabilities and AD/HD.
It was found in several of these studies that increased
risk for neurobehavioral disturbances was positively corre-
lated with an increased number (or total duration) of ex-
posures to anesthesia. These observations suggest an
explanation why alcohol causes more conspicuous or
readily detected neuropsychiatric disturbances than other
apoptogenic agents; i.e., it is more common for the devel-
oping human brain to be exposed on multiple occasions
during critical stages of development to alcohol than to
other apoptogenic drugs. Also relevant to the multiple
exposure hypothesis, we have found [3] that valproate is
one of the most potent anticonvulsants in triggering
neuroapoptosis in the infant rat brain, and there is
evidence from recent multicenter studies [52,53] that daily
exposure of human fetuses to valproate during the third
trimester of pregnancy is associated with a 9 point deficit
in IQ, and that multiple third trimester exposures to
other anticonvulsant drugs ((carbamazepine, lamotrigine,
phenytoin) is associated with impaired verbal abilities at
age 4.5 years.
Our findings document that OLs become vulnerable to
alcohol-induced apoptosis at a maturational stage when
they are just beginning to generate MBP in preparation to
myelinate axons. At each developmental age evaluated
(early, mid, late third trimester) there were abundant OLs
at or beyond this maturational stage. This signifies that
the developing NHP brain is vulnerable to alcohol-
induced oligoapoptosis throughout the entire third trimes-
ter of gestation. Early research focusing on alcohol-
induced apoptosis of neurons established that the window
of vulnerability for that phenomenon coincided with the
brain growth spurt period when billions of recently differ-
entiated neurons are expanding their dendritic surfaces to
accommodate incoming synaptic contacts. Thus, vulner-
ability of neurons appeared to be linked to the period of
rapid synaptogenesis. Our present data suggest that vul-
nerability of OLs is linked to a different functional param-
eter - myelinogenesis. Therefore, it is possible, indeed
likely, that the window of vulnerability for alcohol-
induced oligoapoptosis will be found to have a different
time schedule - one that corresponds to the progression
of myelination events and to the maturational status of
OLs that are responsible for the generation and mainten-
ance of myelin. Our present findings indicate that onset of
vulnerability to the apoptogenic action of alcohol corre-
sponds not to the time when myelin sheaths are formed,
but rather to the earlier time when promyelinating OLs
are beginning to generate constituents of myelin, which in
the human developing brain may occur 2–3 months earl-
ier than myelination of axons is scheduled to begin [54].
The finding that alcohol and anesthetic drugs cause
degeneration of OLs in the WM of the developing fetal
primate brain raises a question how this toxic reaction
might relate to another form of WM injury, periven-
tricular leukomalacia (PVL), which occurs frequently in
the brains of prematurely born human infants and re-
sults in cerebral palsy. The mechanism(s) underlying
PVL are poorly understood, but hypoxia is a leading
candidate, and the pathological reaction is thought to in-
volve death of both neurons and OLs [55]. However, in
animal research pertaining to hypoxic brain injury, the
evidence suggests that death of both neurons and OLs is
triggered by an excitotoxic (not apoptotic) mechanism,
and OLs that are preferentially killed have been identi-
fied as OL progenitors that have not yet begun to gener-
ate constituents of myelin in their cytoplasm [37,56,57].
Another distinction is that OL degeneration in PVL is
focally concentrated in periventricular regions, whereas
OL apoptosis induced by alcohol or anesthetic drugs is
diffusely distributed throughout WM pathways. There-
fore, these are apparently two distinctly different forms
of WM injury. However, if the third trimester brain were
exposed to alcohol or anesthetic drugs and hypoxic con-
ditions at the same time, the two forms of pathology,
each involving death of both neurons and OLs, would
undoubtedly act in concert to increase the severity of
brain injury and long-term neurodevelopmental disabil-
ity. Unfortunately, in pediatric medicine there are set-
tings that are particularly conducive to this type of
compound neurotoxicity. For example, in neonatal in-
tensive care units throughout the world, premature
infants are commonly exposed intermittently or continu-
ously for days or weeks to anesthetic drugs for purposes
of procedural sedation, and these same infants have a
weak respiratory reflex, making them prone to spells of
apnea (hypoxia).
An important limitation of our current findings is that
they do not shed light on how alcohol exerts toxic ef-
fects on the brain during very early stages of develop-
ment. However, Sulik and colleagues [58,59] have
demonstrated that in utero exposure of mice to alcohol
at early stages of embryogenesis markedly increases the
rate of apoptotic cell death among specific embryonic
precursor cell populations that are destined to make im-
portant contributions to the glial and neuronal makeup
of the brain. Collectively, our findings and those of Sulik
et al., support a unifying and research-guiding hypoth-
esis that, although apoptotic cell death is a natural
phenomenon during development, pathological augmen-
tation of apoptotic cell death is unnatural, and repre-
sents an occult mechanism by which alcohol, or other
drugs that mimic alcohol’s apoptogenic action, can dis-
rupt CNS development at any point from early embryo-
genesis to several years after birth.
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Conclusions
In utero exposure of the fetal NHP brain to alcohol on a
single occasion triggers widespread acute apoptotic
death of neurons (previous study) and of OLs (present
study) throughout WM regions of the developing brain.
The rate of OL apoptosis in alcohol-exposed brains was
12.7 times higher than the natural OL apoptosis rate.
OLs become sensitive to the apoptogenic action of alco-
hol when they are just beginning to generate constitu-
ents of myelin in their cytoplasm, and they remain
vulnerable throughout later stages of myelination. There
is growing evidence for a similar apoptotic response of
both neurons and OLs following exposure of the devel-
oping brain to anesthetic and anticonvulsant drugs.
Collectively, this body of evidence raises important ques-
tions regarding the role that neuro and oligo apoptosis
may play in the human condition known as fetal alcohol
spectrum disorder (FASD), and also poses a question
whether other apoptogenic drugs, although long consid-
ered safe for pediatric/obstetric use, may have the
potential to cause iatrogenic FASD-like developmental
disability syndromes.
Methods
Animals
The NHP subjects for this research were fascicularis
(cynomolgus) macaques supplied by Alpha Genesis Inc.,
a non-human primate facility in Yamassee, South Caro-
lina. All NHP experimental procedures were conducted
at the Alpha Genesis facility under the supervision of
one of the authors (NBF) and the Alpha Genesis veterin-
ary staff, and the brains of the fetuses were transported
to the authors’ laboratories for histological evaluation.
All aspects of the research were approved by the Institu-
tional Animal Care and Use Committees of Alpha Gen-
esis Inc. and Washington University School of Medicine,
and were conducted in full accordance with the PHS
Policy on Humane Care and Use of Laboratory Animals.
In the interests of conserving scarce and precious pri-
mate resources, this study was designed to obtain a max-
imal amount of information from as small a number of
NHP fetuses as possible. Thus, the data were obtained
from two alcohol-exposed and one control subject at an
early third trimester age [gestational age 105 to 120 days
(G105-120)], two alcohol-exposed and two control sub-
jects at mid third trimester (G125-140), and one
alcohol-exposed and one control at late third trimester
(G145-155). The full term gestation period for this ma-
caque specie is 160–165 days [60].
Pregnant female NHPs at the desired gestational age
received an intravenous injection of saline (controls) or
alcohol (2.15 g/kg) administered over a 2 minute period
(time zero). Every hour for 6 hours a maintenance dose
(0.2 g/kg) was administered to maintain the blood
alcohol concentration (BAC) in the range of 300–
400 mg/dl. This blood level was chosen because it ap-
proximates the BAC that a human fetus would be ex-
posed to during a moderately heavy maternal binge
drinking episode. For example, see Minion et al. [61]
who reported that 204 patients seen in an adult emer-
gency room for alcohol intoxication had an average BAC
= 467 mg/dl, and some of them had BACs > 600 mg/dl.
Others [62] have reported very similar data, and the al-
cohol literature, in general, documents that individuals
who are dependent on alcohol tolerate and crave much
higher BACs than alcohol-naive individuals can tolerate
[63]. One hour after the last dose of saline or alcohol (i.
e. 8 hours from time zero), the mother was anesthetized,
and the fetus delivered by caesarian section, then imme-
diately euthanized (while still under anesthesia) by per-
fusion of fixative (4% paraformaldehyde in phosphate
buffer). The fetal brains were additionally preserved in
the same fixative for one week after which serial sections
were cut 70 μm thick in the transverse plane for the
forebrain and midbrain and in the sagittal plane for the
brainstem and cerebellum.
Histopathology
The present study was undertaken to follow up on a pre-
liminary observation that in the WM of NHP fetal brains
exposed to alcohol there are large numbers of cellular
profiles that can be detected by immunohistochemical
(IHC) staining with antibodies to activated caspase 3
(AC3), a marker for apoptotic cell death. In order to
confirm that these cells were dying we applied the
DeOlmos cupric silver stain, which selectively stains cells
that are dead or dying [1,64]. We also performed IHC
staining with antibodies to fractin, a breakdown product
of actin that is generated by the proteolytic action of
caspase enzymes in OLs that are undergoing apoptotic
degeneration [37,38]. To clarify the identity and matur-
ational status of these AC3-positive WM cells, we used
immunofluorescent double staining for AC3 or fractin
(markers for apoptosis) and GFAP (marker for astro-
cytes), Iba1 (marker for microglia and macrophages)
[35], platelet-derived growth factor receptor alpha
(PDGFRα) (marker for OL progenitors) [35,39,40], mye-
lin basic protein (MBP) (marker for premyelinating and
myelinating OLs) [40], and neuN (marker for neurons).
In all of the double staining immunofluorescent experi-
ments we counterstained with DAPI, a stain that detects
abnormal changes in nuclear chromatin pattern indica-
tive of apoptotic cell death.
Specific staining protocols were as follows: Our
DeOlmos cupric silver method and non-fluorescent
staining methods for AC3 have been described previ-
ously [1,4,6,11,45]. For immunostaining with MBP
(1:100; MAB 395; Millipore, Billerica, MA, USA), fractin
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(1:400; AB3150; Millipore), Iba1 (1:500; 019–18741;
Wako Chemicals, Richmond, VA), we used the
Vectastain Elite ABC kit with Vector VIP as chromogen
(Vector laboratories, Burlingame, CA, USA). Immuno-
fluorescent detection of caspase-mediated cell death
employed an activated caspase-3 (AC3) rabbit primary
polyclonal antibody (9661B; 1:500; Cell Signaling Tech-
nology, Inc., Danvers, MA). Floating sections were incu-
bated overnight at room temperature (RT). After rinsing
in PBS (3X5 min) they were incubated for 2 hr at RT
with fluorescent goat anti-rabbit Alexa Fluor 555
(1:1000, Invitrogen), rinsed in PBS, and coverslipped
with Vectashield mounting medium. Double-staining for
AC3 with MBP (1:100, MAB 395, Millipore), NeuN
(1:200, MAB 377, Millipore), GFAP (1:500; Mab360;
Millipore) was accomplished using complementary
fluorescent secondary antibodies (1:1000, Alexa Fluor
488). Double-staining for AC3 with PDGFRα employed
a goat anti PDGFRα antibody (1:6; AF-307-NA; R & D
systems; Minneapolis, MN) followed by complementary
fluorescent secondary antibodies (1:100 Alexa Fluor 488
and Alexa Fluor 555). Double-staining for Fractin (1:400;
AB3150, Millipore) and MBP (1:100; MAB 395,
Millipore) was achieved using complementary fluores-
cent (1:1000; Alexa Fluor 488 and Alexa Fluor 555) sec-
ondary antibodies. All immunofluorescent co-labeling
experiments included DAPI in the mounting medium
(Vectashield, Vector) to clarify whether cellular profiles
staining positive for apoptosis markers also showed con-
densation and clumping of nuclear chromatin, an abnor-
mal pattern indicative of apoptotic cell death.
Quantitative methods
For quantification of the glial response we sampled four
regions of WM, the corona radiata, internal capsule,
optic tract and cerebellar peduncle. To sample the four
designated regions we used a template of appropriate
size and shape to fit over a core portion of each desig-
nated area. The same template was used to sample a
given region for each age-matched pair, and anatomical
landmarks were used to ensure that the same anatomical
region was sampled for each member of the pair. Counts
were obtained from 3 consecutive sections from each
brain region. The sampling procedure was computer
assisted with StereoInvestigator software (Microbrightfield
Inc., Williston, VT, USA) so that the total volume of tissue
sampled from each region in a given pair of alcohol and
control brains was controlled at an identical value. The
number of AC3 positive profiles from each WM region
and the volume of tissue sampled were summed for each
brain. Dividing the total volume into the total profile
count yielded a density count (profiles per mm3) for each
alcohol-exposed and each control brain. This provided a
quantitative basis for comparing each age-matched
alcohol/control pair and also for comparing the total
mean density counts for all alcohol-exposed brains com-
bined with the total mean density counts for all control
brains combined.
Statistical analysis
To determine if differences between the experimental and
control brains were statistically significant, an unpaired
students t test with Welch correction, where appropriate,
was performed comparing the total mean (± SEM) density
counts for the alcohol brains combined (n = 5) versus the
total mean (± SEM) density counts for the control brains
combined (n = 4).
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